Connection

Ryan Tedford to Cohort Studies

This is a "connection" page, showing publications Ryan Tedford has written about Cohort Studies.
Connection Strength

0.449
  1. Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension. Circulation. 2016 Jun 14; 133(24):2413-22.
    View in: PubMed
    Score: 0.084
  2. Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2012 Jan 17; 59(3):289-90.
    View in: PubMed
    Score: 0.062
  3. Association of soluble Flt-1 with heart failure and cardiac morphology: The MESA angiogenesis study. J Heart Lung Transplant. 2022 05; 41(5):619-625.
    View in: PubMed
    Score: 0.031
  4. Impact of preoperative liver dysfunction on outcomes in patients with left ventricular assist devices. Eur J Cardiothorac Surg. 2020 05 01; 57(5):920-928.
    View in: PubMed
    Score: 0.028
  5. Impact of Continuous Flow Left Ventricular Assist Device Therapy on Chronic Kidney Disease: A Longitudinal Multicenter Study. J Card Fail. 2020 Apr; 26(4):333-341.
    View in: PubMed
    Score: 0.027
  6. Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension. Eur Respir J. 2019 04; 53(4).
    View in: PubMed
    Score: 0.026
  7. Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2018 02 01; 197(3):388-391.
    View in: PubMed
    Score: 0.024
  8. Acute kidney injury and 1-year mortality after left ventricular assist device implantation. J Heart Lung Transplant. 2018 01; 37(1):116-123.
    View in: PubMed
    Score: 0.023
  9. A Comprehensive Risk Score to Predict Prolonged Hospital Length of Stay After Heart Transplantation. Ann Thorac Surg. 2018 Jan; 105(1):83-90.
    View in: PubMed
    Score: 0.023
  10. Pre-operative proteinuria in left ventricular assist devices and clinical outcome. J Heart Lung Transplant. 2018 01; 37(1):124-130.
    View in: PubMed
    Score: 0.023
  11. What's in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension. Int J Cardiol. 2017 Aug 01; 240:386-391.
    View in: PubMed
    Score: 0.022
  12. Histamine H2 Receptor Antagonists, Left?Ventricular Morphology, and Heart?Failure?Risk: The MESA Study. J Am Coll Cardiol. 2016 Apr 05; 67(13):1544-1552.
    View in: PubMed
    Score: 0.021
  13. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circulation. 2016 Mar 29; 133(13):1240-8.
    View in: PubMed
    Score: 0.021
  14. Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center. ASAIO J. 2014 Mar-Apr; 60(2):193-8.
    View in: PubMed
    Score: 0.018
  15. Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension. J Rheumatol. 2011 Nov; 38(11):2410-8.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.